Opioid epidemic: ex-DEA official says Congress is protecting drug makers
Joseph Rannazzisi accuses lawmakers of putting US pharmaceutical companies’ $9bn-a-year trade in opioid painkillers ahead of a public health crisis
A former top Drug Enforcement Administration (DEA) official has accused Congress of putting pharmaceutical company profits ahead of public health in the battle to combat the US’s prescription opioid epidemic.
Joseph Rannazzisi, head of the DEA office responsible for preventing prescription medicine abuse until last year, said drug companies and their lobbyists have a “stranglehold” on Congress to protect a $9bn a year trade in opioid painkillers claiming the lives of nearly 19,000 people a year.
More From Around the Web
Check out these Articles
- More Older Patients at Risk for Drug-Drug Interaction, Indicates New Study
- Owen Smith worked as PR chief for biotech firm hit by $762m fine
- Shire buys US firm ViroPharma to enhance rare diseases treatments
- The European court of human rights judgments that transformed British law
- French sex toys go organic for eco-conscious consumers
- As a thalidomider, ‘I feel I’m being treated like a scrounger’ | Davi...
- Task Force of Physicians Encourages Use of PMPs to Help Protect Patients Fr...
- National recall of two batches of widely used hospital anaesthetic
- Plantwatch: The pharmacy flourishing in gardens and fields
- Peptineo Inks Exclusive Option for Drug Delivery Technologies from Lawrence...
- VIRUN® NutraBIOsciences™ Granted Patent 261124 in India, Redesigns Websi...